Biologics which contain plant extracts as a base are termed as plant-based biologics. As compared to mammalian cell culture-based drugs, plant-based drugs are easier to process, and are more economical to produce on a larger scale, thereby making it a suitable method for a multitude of diseases such as Alzheimer’s, cancer, HIV/AIDS and Ebola, amongst others. The global plant-based biologics market is expected to see huge growth during the forecast years due to the rise in chronic diseases and geriatric population in countries like the U.S., China, Japan, Brazil and India, amongst others.
Request for Sample Copy of This Report@ https://www.absolutemarketsinsights.com/request_sample.php?id=791
The COVID-19 pandemic is expected to have a positive impact on the global plant-based biologics market in the coming years, thereby making the market an attractive source of investment. Plant-based drugs and vaccines are being developed by the market participants in the fight against coronavirus. Medicago and GlaxoSmithKline, for instance, have developed a plant-based vaccine called as CoVLP which is currently in clinical trial. The ability of plant based products to target specific molecules, coupled with the ease of extraction, is expected to play a major role in the development of COVID-19 drugs and vaccines, thereby driving the growth of the global plant-based biologics market.
The detailed research study provides qualitative and quantitative analysis of plant-based biologics market. The market has been analyzed from demand as well as supply side. The demand side analysis covers market revenue across regions and further across all the major countries. The supply side analysis covers the major market players and their regional and global presence and strategies. The geographical analysis done emphasizes on each of the major countries across North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
Enquiry Before Buying @ https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=791
Key Findings of the Report:
- In terms of revenue, global plant-based biologics market is expected to reach US$ 250.17 Mn by 2028 growing at a CAGR of 26.45% over the forecast period.
- North America accounted for the highest market share in the global plant-based biologics market in 2019. The presence of prominent market participants such as iBio LLC, Pfizer Inc., Planet Biotechnology Inc., coupled with the higher investment in the development of plant-based drugs based on algae and tobacco in the U.S. and Canada plays a vital role for the higher share of North America in the global plant-based biologics market. But, the APAC region is expected to show the highest growth during the forecast years in the global plant-based biologics market due to the rising demand for traditional herbs-based products in countries such as India, China, Japan, South Korea, amongst others.
- Plant-based biologics for the treatment and prevention of Alzheimer's disease and cancer are expected to become popular in the coming years. The ability of plant-based drugs to target the cancerous cells in human beings, coupled with the ease of processing these drugs, is expected to lead their adoption for the treatment of various forms of cancer.
- Some of the players operating in the plant-based biologics market are Byondis, eleva GmbH, Eversea Inc, iBio, Inc, Icon Genetics GmbH, InVitria, Kentucky BioProcessing, Inc., Leaf Expression Systems, Mapp Biopharmaceutical, Inc., Medicago Inc., OnePointOne, Inc., Pfizer Inc., . Planet Biotechnology Inc., PlantForm, Protalix Biotherapeutics, Ventria Bioscience Inc., Zea Biosciences, amongst others.
Request for Customization@ https://www.absolutemarketsinsights.com/request_for_customization.php?id=791
Global Plant-based Biologics Market:
- By Clinical Trial
- Phase I
- Phase II
- Others
- By Source
- Tobacco, tobacco cells, tobacco leaves
- Nicotiana benthamiana leaves
- Carrot cell culture
- Rice seeds
- Moss
- Algae
- Duckweed Leafy Biomass
- Others
- By Product
- Taliglucerase alfa
- ZMApp
- PRX-102
- HAI-05
- Others
- By Diseases
- HIV/AIDS
- Ebola virus
- Cholera
- Leprosy
- Tuberculosis
- Fabry Disease
- Anthrax
- Pompe Disease
- Influenza
- Type A
- Type B
- Type c
- Alzheimer
- Respiratory Syndromes
- Gaucher disease
- Cancer
- Others
- By Mode of Administration
- Intramuscular
- Oral Administration
- Others
- By End Users
- Hospitals
- Clinics
- Primary Care Centers
- Others
- By Region
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Get Full Information of this premium report@ https://www.absolutemarketsinsights.com/reports/Plant-Based-Biologics-2020-2028-791
About Us:
Absolute Markets Insights strives to be your main man in your business resolve by giving you insight into your products, market, marketing, competitors, and customers. Visit …
Contact Us:
Email id: [email protected]
Contact Name: Shreyas Tanna
Phone: +91-740-024-2424